Zobrazeno 1 - 10
of 773
pro vyhledávání: '"Alan S., Go"'
Autor:
Robin L. Baudier, Paula F. Orlandi, Wei Yang, Hsiang-Yu Chen, Nisha Bansal, J. Walker Blackston, Jing Chen, Rajat Deo, Mirela Dobre, Hua He, Jiang He, Ana C. Ricardo, Tariq Shafi, Anand Srivastava, Dawei Xie, Katalin Susztak, Harold I. Feldman, Amanda H. Anderson, Lawrence J. Appel, MD, Debbie Cohen, MD, Laura Dember, MD, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, Mark L. Unruh, MD
Publikováno v:
Kidney Medicine, Vol 6, Iss 8, Pp 100850- (2024)
Rationale & Objective: Matrix metalloproteinase 2 (MMP-2) plays an important role in the development of fibrosis, the final common pathway of chronic kidney disease (CKD). This study aimed to assess the relationship between repeated measures of MMP-2
Externí odkaz:
https://doaj.org/article/252319ba1a8a4904a23462feb4c12231
Autor:
Rosalba Hernandez, Dawei Xie, Xue Wang, Neil Jordan, Ana C. Ricardo, Amanda H. Anderson, Clarissa J. Diamantidis, John W. Kusek, Kristine Yaffe, James P. Lash, Michael J. Fischer, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Publikováno v:
Kidney Medicine, Vol 6, Iss 4, Pp 100790- (2024)
Rationale & Objective: The extent to which depression affects the progression of chronic kidney disease (CKD) and leads to adverse clinical outcomes remains inadequately understood. We examined the association of depressive symptoms (DS) and antidepr
Externí odkaz:
https://doaj.org/article/372492a36bc0499d8b10263e02f5ba88
Autor:
Sushmita Malik, Shanshan Gustafson, Huai-En R. Chang, Yonas Tamrat, Alan S. Go, Natalia Berry
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Atrial Fibrillation (AF) is the leading cause of stroke, which can be reduced by 70% with appropriate oral anticoagulation (OAC) therapy. Nationally, appropriate anticoagulation rates for patients with AF with elevated thromboembo
Externí odkaz:
https://doaj.org/article/f98b68dfbecd4096b7367de5757a5254
Autor:
Ruth F. Dubin, Rajat Deo, Yue Ren, Jianqiao Wang, Zihe Zheng, Haochang Shou, Alan S. Go, Afshin Parsa, James P. Lash, Mahboob Rahman, Chi-yuan Hsu, Matthew R. Weir, Jing Chen, Amanda Anderson, Morgan E. Grams, Aditya Surapaneni, Josef Coresh, Hongzhe Li, Paul L. Kimmel, Ramachandran S. Vasan, Harold Feldman, Mark R. Segal, Peter Ganz, CRIC Study Investigators, CKD Biomarkers Consortium
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Progression of chronic kidney disease (CKD) portends myriad complications, including kidney failure. In this study, we analyze associations of 4638 plasma proteins among 3235 participants of the Chronic Renal Insufficiency Cohort Study with
Externí odkaz:
https://doaj.org/article/e4b35c37bd9f4b68928efff3e22388ac
Autor:
David M. Charytan, Wenbo Wu, Mengling Liu, Zhong-Min Li, Kurunthachalam Kannan, Leonardo Trasande, Vineet Kumar Pal, Sunmi Lee, Howard Trachtman, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS.
Publikováno v:
Kidney Medicine, Vol 6, Iss 3, Pp 100778- (2024)
Rationale & Objective: This study aimed to assess the effect of exposure to organic pollutants in adults with chronic kidney disease (CKD). Study Design: This was a cross-sectional and longitudinal analysis. Setting and Participants: Forty adults enr
Externí odkaz:
https://doaj.org/article/4494229931ba4c97a2a8fd14827f7568
Autor:
Alexander S. Leidner, Xuan Cai, Leila R. Zelnick, Jungwha Lee, Nisha Bansal, Andreas Pasch, Mayank Kansal, Jing Chen, Amanda Hyre Anderson, James H. Sondheimer, James P. Lash, Raymond R. Townsend, Alan S. Go, Harold I. Feldman, Sanjiv J. Shah, Myles Wolf, Tamara Isakova, Rupal C. Mehta, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Publikováno v:
Kidney Medicine, Vol 5, Iss 11, Pp 100723- (2023)
Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical studies implicates excess levels of fibroblast grow
Externí odkaz:
https://doaj.org/article/8c1713b6e8d342b98764f7e852bba1ef
Autor:
Jesse K. Fitzpatrick, Rishi V. Parikh, Steven A. Hamilton, Andrew P. Ambrosy, Thida C. Tan, Nisha Bansal, Alan S. Go, for the CRIC Study Investigators
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Adults with chronic kidney disease (CKD) are at increased risk for developing heart failure (HF). However, longitudinal cardiac remodeling in CKD has not been well-characterized and its association with HF outcomes remains unknown. We evalua
Externí odkaz:
https://doaj.org/article/61280b3e32a54835acc0cc33454f39a8
Autor:
Rishi V. Parikh, Alan S. Go, Ankeet S. Bhatt, Thida C. Tan, Amanda R. Allen, Kent Y. Feng, Steven A. Hamilton, Andrew S. Tai, Jesse K. Fitzpatrick, Keane K. Lee, Sirtaz Adatya, Harshith R. Avula, Dana R. Sax, Xian Shen, Joaquim Cristino, Alexander T. Sandhu, Paul A. Heidenreich, Andrew P. Ambrosy
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 19 (2023)
Background There is a need to develop electronic health record–based predictive models for worsening heart failure (WHF) events across clinical settings and across the spectrum of left ventricular ejection fraction (LVEF). Methods and Results We st
Externí odkaz:
https://doaj.org/article/01b708908f5f4ebb981fd04d26df5734
Autor:
David R. Vinson, Adina S. Rauchwerger, Chandu A. Karadi, Judy Shan, E. Margaret Warton, Jennifer Y. Zhang, Dustin W. Ballard, Dustin G. Mark, Erik R. Hofmann, Dale M. Cotton, Edward J. Durant, James S. Lin, Dana R. Sax, Luke S. Poth, Stephen H. Gamboa, Meena S. Ghiya, Mamata V. Kene, Anuradha Ganapathy, Patrick M. Whiteley, Sean C. Bouvet, Leon Babakhanian, Edward W. Kwok, Matthew D. Solomon, Alan S. Go, Mary E. Reed, on behalf of the Kaiser Permanente CREST Network
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-21 (2023)
Abstract Background Management of adults with atrial fibrillation (AF) or atrial flutter in the emergency department (ED) includes rate reduction, cardioversion, and stroke prevention. Different approaches to these components of care may lead to vari
Externí odkaz:
https://doaj.org/article/f100ca148e5942cfbde49a841dc551d3
Autor:
Erica P. Gunderson, Mara Greenberg, Baiyang Sun, Nancy Goler, Alan S. Go, James M. Roberts, Mai N. Nguyen‐Huynh, Wei Tao, Stacey E. Alexeeff
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 15 (2023)
Background Clinical risk factors, a single blood pressure (BP) measurement, current biomarkers, and biophysical parameters can effectively identify risk of early‐onset preeclampsia but have limited ability to predict later‐onset preeclampsia and
Externí odkaz:
https://doaj.org/article/f8f2b480e6e74fc5908fbe88c73318d2